cbdMD (AMEX:YCBD) reported $7.86 million in sales this quarter. This is a 19.75 percent decrease over sales of $9.79 million the same period last year.
CICC Initiates Coverage On Livent with Outperform Rating, Announces Price Target of $27.3
CICC initiates coverage on Livent (NYSE:LTHM) with a Outperform rating and announces Price Target of $27.3.